Exagen appoints Paul Kim to board of directors; Kim is CFO of Fulgent Genetics

EXAGEN INC.

Paul Kim appointed to Exagen board as Class II director effective July 24, 2023.
Kim also appointed to Audit Committee and Compensation Committee.
Kim has served as CFO of Fulgent Genetics (FLGT) since 2016; previously CFO of Cogent, Inc.
Kim received option to purchase 15,000 shares vesting over 3 years; standard director compensation.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Paul Kim

Class II Director

XGN · EXAGEN INC.

Effective: 2023-07-24
Filed: July 24, 2023, 7:59 PM ET

the Board appointed Paul Kim to serve as a Class II director, with an initial term expiring at the Company’s 2024 annual meeting of stockholders, filling the vacancy on the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Paul Kim was appointed as Class II Director at EXAGEN INC..

Action: appointed
Role: Class II Director

Exact text from the filing

the Board appointed Paul Kim to serve as a Class II director, with an initial term expiring at the Company’s 2024 annual meeting of stockholders, filling the vacancy on the Board.

View on SEC.gov

EXAGEN INC. filing history →

Source: SEC EDGAR

accession 0001274737-23-000074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.